Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析

◆英語タイトル:Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12933
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nanjing Pharmaceutical Co Ltd (600713) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nanjing Pharmaceutical Co Ltd (NPC) focuses on the distribution of a wide range of pharmaceutical products and other products. It provides a range of pharmaceutical supply chain services and health chain services. The company maintains distribution relationships with several companies in China. NPC also provides traditional Chinese medicine, logistics services and rent and property management. NPC provides its pharmaceuticals products to hospitals, pharmacies, community health institutions, chain pharmacies and rural township hospitals, clinics and other non-public medical institutions and commercial distribution enterprises. The company provides its services to Soviet Union; and Anhui, Jiangsu, Hubei, Sichuan, Yunnan and Fujian provinces covering several cities across China. NPC is headquartered in NanJing, Jiangsu, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Nanjing Pharmaceutical Co Ltd – Key Facts 5
Nanjing Pharmaceutical Co Ltd – Key Employees 6
Nanjing Pharmaceutical Co Ltd – Major Products and Services 7
Nanjing Pharmaceutical Co Ltd – History 8
Nanjing Pharmaceutical Co Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 12
Company Overview 12
Nanjing Pharmaceutical Co Ltd – Business Description 13
Nanjing Pharmaceutical Co Ltd – SWOT Analysis 14
SWOT Analysis – Overview 14
Nanjing Pharmaceutical Co Ltd – Strengths 14
Nanjing Pharmaceutical Co Ltd – Weaknesses 15
Nanjing Pharmaceutical Co Ltd – Opportunities 16
Nanjing Pharmaceutical Co Ltd – Threats 17
Nanjing Pharmaceutical Co Ltd – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 26
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 27
Nanjing Pharmaceutical Co Ltd, Recent Deals Summary 28
Section 5 – Appendix 29
Methodology 29
Ratio Definitions 29
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Nanjing Pharmaceutical Co Ltd, Key Facts 5
Nanjing Pharmaceutical Co Ltd, Key Employees 6
Nanjing Pharmaceutical Co Ltd, Major Products and Services 7
Nanjing Pharmaceutical Co Ltd, History 8
Nanjing Pharmaceutical Co Ltd, Subsidiaries 10
Nanjing Pharmaceutical Co Ltd, Key Competitors 18
Nanjing Pharmaceutical Co Ltd, Ratios based on current share price 19
Nanjing Pharmaceutical Co Ltd, Annual Ratios 20
Nanjing Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 21
Nanjing Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 22
Nanjing Pharmaceutical Co Ltd, Interim Ratios 24
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 26
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 27
Nanjing Pharmaceutical Co Ltd, Recent Deals Summary 28
Currency Codes 29
Capital Market Ratios 29
Equity Ratios 30
Profitability Ratios 30
Cost Ratios 31
Liquidity Ratios 31
Leverage Ratios 32
Efficiency Ratios 32

List of Figures
Nanjing Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 23
Nanjing Pharmaceutical Co Ltd, Ratio Charts 25
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 26
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 27

★海外企業調査レポート[Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Penn Bancshares, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' National Penn Bancshares, Inc. …
  • MGM China Holdings Ltd:企業の戦略・SWOT・財務情報
    MGM China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary MGM China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Transgenomic Inc (TBIO)-医療機器分野:企業M&A・提携分析
    Summary Transgenomic Inc (Transgenomic) is a developer and provider of diagnostic tools and services. The company’s products include ICEme Kits, and genetic assays and platforms. It offers genetic assays and platforms such as PCR reagents, chromatography, genetic analysis kits, hanabi cytogenetic sy …
  • MRI Interventions, Inc (MRIC):企業概要、財務及び戦略的SWOT分析
    Summary MRI Interventions, Inc (MRI Interventions) is a medical device company. The company develops and commercializes platforms for performing minimally invasive surgical procedures. Its product platforms include ClearPoint system and ClearTrace system. MRI Interventions' ClearPoint system is a su …
  • Krebs Biochemicals & Industries Ltd (KREBSBIO):企業の財務及び戦略的SWOT分析
    Summary Krebs Biochemicals & Industries Ltd (KBIL) is a pharmaceutical company that manufactures and markets painkillers, anti-asthmatic and anti-HIV drugs for the healthcare market. The company’s products include simvastatin, lovastatin, ephedrine, pseudo ephedrine, adenine, atorvastatin intermedia …
  • Energias de Portugal S.A. (EDP):企業のM&A・提携動向(石油・ガス分野)
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and explores for, produces, transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation ass …
  • Tenaska, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tenaska, Inc. Mergers and Acqui …
  • Aktif Yatırım Bankası Anonim Sirketi:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Aktif Yatırım Bankası Anonim Sirketi" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetr …
  • Breeze-Eastern Corporation:企業の戦略・SWOT・財務情報
    Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report Summary Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Curemark, LLC(製薬・医療分野):企業M&A動向
    Summary Curemark, LLC (Curemark) is a biopharmaceutical company. It develops and markets products for both children and adults with neurological disorders. The company develops therapies that treat various diseases. Its pipeline products include CM-AT, CM-4612.ADHD, CM-PK, CM-182 and CM-1212. The co …
  • Trident Systems Incorporated:企業の戦略・SWOT・財務情報
    Trident Systems Incorporated - Strategy, SWOT and Corporate Finance Report Summary Trident Systems Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Western Sizzlin Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Western Sizzlin Corporation Mer …
  • Britannia Pharmaceuticals Limited:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • 1366 Technologies Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary 1366 Technologies Inc. (1366 Tech) is a renewable energy company. The company develops manufacturing solutions for silicon cell manufacturers. Its wafer manufacturing technology is a capital intensive process, which limits cell efficiency potential for manufacturers due to mass quality defec …
  • Ansys, Inc.の企業概要及び財務/SWOT分析
    Ansys, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Ansys, Inc. annual and quarterly forecasts made by stock market experts. The report also enables direct comparison …
  • Dermira Inc (DERM):企業財務及び戦略的SWOT分析
    Summary Dermira Inc (Dermira) focuses on the development and commercialization of novel therapies for dermatologic diseases. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atopic dermatitis and acne. Its pipeline products include cimzia, …
  • WaferGen Biosystems, Inc.:企業のM&A・提携・投資分析
    WaferGen Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's WaferGen Biosystems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Indraprastha Gas Limited (IGL):企業の財務及び戦略的SWOT分析
    Summary Indraprastha Gas Limited (IGL) is a natural gas distribution company that supplies to its customers in the domestic and commercial sectors. The company's products include compressed natural gas and piped natural gas. It provides compressed natural gas for transport; piped natural gas for coo …
  • National Heart Lung and Blood Institute-製薬・医療分野:企業M&A・提携分析
    Summary National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs …
  • Takeda Pharmaceuticals U.S.A., Inc.(製薬・医療分野):企業M&A動向
    Summary Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products. Its products include pioglitazone, pioglitazone and metformin HCl, pioglitazone and glimepiride, lubiprostone, colchicine, USP, dexlans …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆